Parkside Financial Bank & Trust Blueprint Medicines Corp Transaction History
Parkside Financial Bank & Trust
- $772 Million
- Q1 2025
A detailed history of Parkside Financial Bank & Trust transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 109 shares of BPMC stock, worth $13,968. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109
Previous 84
29.76%
Holding current value
$13,968
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
391Shares Held
68.5MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$852 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$851 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$694 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$493 Million5.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$394 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.65B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...